MediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
January 17, 2025 18:18 ET
|
INNOVATE Corp.
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe transdermal GFR (tGFR) methodology has...
INNOVATE Corp. Portfolio Company R2 Technologies Announces Another Record-Breaking Quarter and Partnerships with Woodhouse Spas and Top Skincare Brands
November 20, 2024 08:22 ET
|
INNOVATE Corp.
NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- R2 Technologies, Inc., the world leader in CryoAesthetics® with its cutting-edge Glacial Skin systems (“R2”), a portfolio company of INNOVATE Corp. (NYSE:...
INNOVATE Corp. Announces Third Quarter 2024 Results
November 06, 2024 16:03 ET
|
INNOVATE Corp.
- Infrastructure: DBM Global third quarter revenue of $232.8 million -- Life Sciences: R2 reports record worldwide system unit sales growth in the third quarter -- Spectrum: Broadcasting's delivered...
INNOVATE Corp. to Report Third Quarter 2024 Results on November 6th
October 16, 2024 16:05 ET
|
INNOVATE Corp.
NEW YORK, Oct. 16, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the third quarter 2024 on...
INNOVATE Corp. Regains Compliance with NYSE Minimum Price Requirement
September 03, 2024 16:05 ET
|
INNOVATE Corp.
NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it has received a letter from the New York Stock Exchange (“NYSE”) dated...
INNOVATE Corp. Announces Second Quarter 2024 Results
August 07, 2024 16:04 ET
|
INNOVATE Corp.
- Infrastructure: DBM Global achieved second quarter revenue of $305.2 million -- Life Sciences: R2 achieved record Glacial system sales in North America in the second quarter -- Spectrum:...
INNOVATE Corp. Announces Extension of Effective Date for Reverse Stock Split to August 8, 2024
July 29, 2024 08:30 ET
|
INNOVATE Corp.
NEW YORK, July 29, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that the Company is amending the effective date...
INNOVATE Corp. Announces 1-for-10 Reverse Stock Split of the Company’s Common Stock
July 19, 2024 09:10 ET
|
INNOVATE Corp.
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE), a diversified holding company, announced today that its Board of Directors has approved a...
INNOVATE Corp. to Report Second Quarter 2024 Results on August 7th
July 17, 2024 16:05 ET
|
INNOVATE Corp.
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- INNOVATE Corp. (NYSE: VATE) (“INNOVATE” or the “Company”) announced today that it will release its financial results for the second quarter 2024 on...
INNOVATE Corp. Announces First Quarter 2024 Results
May 07, 2024 16:05 ET
|
INNOVATE Corp.
- Infrastructure: DBM Global achieved first quarter revenue of $307.9 million -- Life Sciences: R2 delivered record North America system sales in the first quarter 2024 -- Spectrum: Broadcasting's...